These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 19203562)

  • 1. A combination of cetirizine and pseudoephedrine has therapeutic benefits when compared to single drug treatment in allergic rhinitis.
    Badorrek P; Dick M; Schauerte A; Hecker H; Murdoch R; Luettig B; Hohlfeld JM; Krug N
    Int J Clin Pharmacol Ther; 2009 Feb; 47(2):71-7. PubMed ID: 19203562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of an oral formulation of cetirizine and prolonged-release pseudoephedrine versus xylometazoline nasal spray in nasal congestion.
    Stübner UP; Toth J; Marks B; Berger UE; Burtin B; Horak F
    Arzneimittelforschung; 2001 Nov; 51(11):904-10. PubMed ID: 11765592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of desloratadine/pseudoephedrine combination vs its components in seasonal allergic rhinitis.
    Grubbe RE; Lumry WR; Anolik R
    J Investig Allergol Clin Immunol; 2009; 19(2):117-24. PubMed ID: 19476015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Desloratadine and Levocetirizine in Patients with Cedar Pollen-Induced Allergic Rhinitis: A Randomized, Double-Blind Study.
    Yonekura S; Okamoto Y; Sakurai D; Iinuma T; Sakurai T; Yoneda R; Kurita J; Hanazawa T; Kawasaki Y
    Int Arch Allergy Immunol; 2019; 180(4):274-283. PubMed ID: 31618733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis.
    Bachert C
    Clin Ther; 2009 May; 31(5):921-44. PubMed ID: 19539095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of an extended-release formulation of desloratadine and pseudoephedrine vs the individual components in the treatment of seasonal allergic rhinitis.
    Pleskow W; Grubbe R; Weiss S; Lutsky B
    Ann Allergy Asthma Immunol; 2005 Mar; 94(3):348-54. PubMed ID: 15801245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy and pharmacokinetic profiles of intranasal and oral cetirizine in a repeated allergen challenge model of allergic rhinitis.
    Korsgren M; Andersson M; Borgå O; Larsson L; Aldén-Raboisson M; Malmqvist U; Greiff L
    Ann Allergy Asthma Immunol; 2007 Apr; 98(4):316-21. PubMed ID: 17458426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desloratadine and pseudoephedrine combination therapy as a comprehensive treatment for allergic rhinitis and nasal congestion.
    Anolik R
    Expert Opin Drug Metab Toxicol; 2009 Jun; 5(6):683-94. PubMed ID: 19473112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of fexofenadine/pseudoephedrine combination tablet on nasal obstruction in patients with allergic rhinitis using rhinomanometry: A randomized controlled trial.
    Nakamura Y; Yokoyama Y; Koyama S; Fujiwara K; Nakamori M; Fujii T; Enomoto T; Takeuchi H
    Asian Pac J Allergy Immunol; 2024 Jun; 42(2):147-153. PubMed ID: 33638625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of an oral formulation of cetirizine and prolonged-release pseudoephedrine versus budesonide nasal spray in the management of nasal congestion in allergic rhinitis.
    Zieglmayer UP; Horak F; Toth J; Marks B; Berger UE; Burtin B
    Treat Respir Med; 2005; 4(4):283-7. PubMed ID: 16086601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cetirizine reduces cytokines and inflammatory cells in children with perennial allergic rhinitis.
    Ciprandi G; Tosca MA; Milanese M; Ricca V
    Eur Ann Allergy Clin Immunol; 2004 Jun; 36(6):237-40. PubMed ID: 15329007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Montelukast plus cetirizine in the prophylactic treatment of seasonal allergic rhinitis: influence on clinical symptoms and nasal allergic inflammation.
    Kurowski M; Kuna P; Górski P
    Allergy; 2004 Mar; 59(3):280-8. PubMed ID: 14982509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of desloratadine/pseudoephedrine tablet, 2.5/120 mg two times a day, versus individual components in the treatment of patients with seasonal allergic rhinitis.
    Chervinsky P; Nayak A; Rooklin A; Danzig M
    Allergy Asthma Proc; 2005; 26(5):391-6. PubMed ID: 16450574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Onset-of-action for antihistamine and decongestant combinations during an outdoor challenge.
    Georgitis JW; Meltzer EO; Kaliner M; Weiler J; Berkowitz R
    Ann Allergy Asthma Immunol; 2000 Apr; 84(4):451-9. PubMed ID: 10795655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-allergic drug testing in an environmental challenge chamber is suitable both in and out of the relevant pollen season.
    Badorrek P; Dick M; Hecker H; Schaumann F; Sousa AR; Murdoch R; Hohlfeld JM; Krug N
    Ann Allergy Asthma Immunol; 2011 Apr; 106(4):336-41. PubMed ID: 21457883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cetirizine and pseudoephedrine retard, given alone or in combination, in patients with seasonal allergic rhinitis.
    Grosclaude M; Mees K; Pinelli ME; Lucas M; Van de Venne H
    Rhinology; 1997 Jun; 35(2):67-73. PubMed ID: 9299654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A proof-of-concept study of the effect of a novel H3-receptor antagonist in allergen-induced nasal congestion.
    Barchuk WT; Salapatek AM; Ge T; D'Angelo P; Liu X
    J Allergy Clin Immunol; 2013 Oct; 132(4):838-46.e1-6. PubMed ID: 23791513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety relative to placebo of an oral formulation of cetirizine and sustained-release pseudoephedrine in the management of nasal congestion.
    Horak F; Toth J; Marks B; Stübner UP; Berger UE; Jäger S; Burtin B; Duby C
    Allergy; 1998 Sep; 53(9):849-56. PubMed ID: 9788685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of an H3 receptor antagonist (PF-03654746) with fexofenadine on reducing allergic rhinitis symptoms.
    Stokes JR; Romero FA; Allan RJ; Phillips PG; Hackman F; Misfeldt J; Casale TB
    J Allergy Clin Immunol; 2012 Feb; 129(2):409-12, 412.e1-2. PubMed ID: 22196768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of cetirizine and terfenadine versus placebo in the symptomatic management of seasonal allergic rhinitis.
    Lockey RF; Widlitz MD; Mitchell DQ; Lumry W; Dockhorn R; Woehler T; Grossman J
    Ann Allergy Asthma Immunol; 1996 May; 76(5):448-54. PubMed ID: 8630719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.